TherapeuticsMD (TXMD) FCF Margin Growth (3y) (2014 - 2026)
Powered by 
Analysis
TherapeuticsMD (TXMD) FCF Margin Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 1,461.00 |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | -2,596.00 |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 874.00 |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 982.00 |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 1,832.00 |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 930.00 |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 1,733.00 |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 9,545.00 |
| 10 | TherapeuticsMD | 25.35 Mn | 16.16 Mn | - | 75,532.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75,532.00 |
| Mar 31, 2026 | 222,654.00 |
| Dec 31, 2025 | 900.00 |
| Sep 30, 2025 | -487,710.00 |
| Jun 30, 2025 | 598,830.00 |
| Mar 31, 2025 | 275,542.00 |
| Dec 31, 2024 | -25,445.00 |
| Sep 30, 2024 | 13,719.00 |
| Jun 30, 2024 | 73,647.00 |
| Mar 31, 2024 | 12,035.00 |
| Dec 31, 2023 | -131,321.00 |
| Sep 30, 2023 | -983,710.00 |
| Jun 30, 2023 | -14,274.00 |
| Mar 31, 2023 | -177,674.00 |
| Dec 31, 2022 | 35,483.00 |
| Sep 30, 2022 | 511,928.00 |
| Jun 30, 2022 | -510,366.00 |
| Mar 31, 2022 | -160,401.00 |
| Dec 31, 2021 | 81,301.00 |
| Sep 30, 2021 | 83,107.00 |